Risk Factors and Outcomes Analyses at 36 Months of a Prospective, Randomized, Multicenter, Trial of Daclizumab Induction in Simultaneous Kidney–Pancreas Transplant Recipients

✍ Scribed by R.J. Stratta; R.R. Alloway; A. Lo; E.E. Hodge

• Book ID: 116931623
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 71 KB
• Volume: 37
• Category: Article
• ISSN: 0041-1345
• DOI: 10.1016/j.transproceed.2005.09.061